Literature DB >> 9242730

Nicotine inhibits slowly inactivating K+ currents in rat cultured striatal neurons.

B Hamon1, J Glowinski, C Giaume.   

Abstract

As shown on cultured striatal neurons recorded in whole-cell configuration, both acetylcholine (in the presence of atropine) and nicotine reduced voltage-dependent outward currents. Although, at early postnatal ages, outward currents in these cells are mainly carried by rapidly and slowly inactivating K+ channels, these inhibitions resulted from a selective and reversible effect on the slowly inactivating K+ conductance (IK+). This action was blocked by the nicotinic antagonist dihydro-beta-erythroïdine and reproduced by nicotinic agonists. When neurons were recorded under current-clamp conditions, nicotine increased reversibly their firing rate generated by step depolarizations. Therefore, in addition to its well documented muscarinic effects, acetylcholine also controls K+ currents in striatal neurons through mechanisms mediated by nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9242730     DOI: 10.1007/s004240050447

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  4 in total

1.  Cellular basis for the olfactory response to nicotine.

Authors:  Bruce Bryant; Jiang Xu; Valery Audige; Fritz W Lischka; Nancy E Rawson
Journal:  ACS Chem Neurosci       Date:  2010-02-26       Impact factor: 4.418

2.  Neurochemical and electrophysiological characteristics of rat striatal neurons in primary culture.

Authors:  Torsten Falk; Shiling Zhang; Emilie L Erbe; Scott J Sherman
Journal:  J Comp Neurol       Date:  2006-01-10       Impact factor: 3.215

3.  Nicotine inhibits potassium currents in Aplysia bag cell neurons.

Authors:  Sean H White; Raymond M Sturgeon; Neil S Magoski
Journal:  J Neurophysiol       Date:  2016-02-10       Impact factor: 2.714

4.  Nicotinic activation of laterodorsal tegmental neurons: implications for addiction to nicotine.

Authors:  Masaru Ishibashi; Christopher S Leonard; Kristi A Kohlmeier
Journal:  Neuropsychopharmacology       Date:  2009-07-22       Impact factor: 7.853

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.